跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KELZY 2 MG/0,02 MG COMPRIMIDOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
KELZY 2 MG/0,02 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Approved
STANDARD
KELZY 2 MG/0,02 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Exeltis Healthcare S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 23, 2024
Approval ID
8bdb47a1aad8ea71
Company
Exeltis Healthcare S.L.
Type
Standard
Approval Details
Approval Id
8bdb47a1aad8ea71
Drug Cima Aemps Name
KELZY 2 MG/0,02 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Register Number
89586
Holder Company Name
Exeltis Healthcare S.L.
Marketing Company Name
Exeltis Healthcare S.L.
Authorization Date
2024-05-23
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
2 mg/0,02 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Exeltis Healthcare S.L.
Active Ingredients
DIENOGEST
2 mg
ETINILESTRADIOL
0,02 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 23, 2024
Approval ID
8bdb47a1aad8ea71
Type
Standard
Back to CIMA-AEMPS Approvals